 |
Bioeclipse Therapeutics
Last updated: October 11, 2024
CEO Pamela Contag
USA | Funding: $15.7M (+)
Website: https://www.bioeclipse.com/
BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology.
Website: https://www.bioeclipse.com/
BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology.
